4057, 4057M Screw-In |
Product Characteristics | |||
|---|---|---|---|---|
| US Market Release | Aug-88 | Serial Number Prefix | XQ or LAN | |
| Registered US Implants | 10,100 | Type and/or Fixation | Transvenous, V or A, Screw-in | |
| Estimated Active US Implants | 1,800 | Polarity | Unipolar | |
| Advisories | None | Steroid | No | |
| Ventricular Placement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| System Longevity Study Results |
|
|||||||||
| Number of Leads Enrolled in Study | 259 | |||||||||
| Cumulative Months of Follow-Up | 15,351 | |||||||||
| Number of Leads Active in Study | 9 | |||||||||
| Qualifying Complications | 7 Total | |||||||||
| Conductor Fracture | 2 | |||||||||
| Extra Cardiac Stimulation | 2 | |||||||||
| Failure to Capture | 2 | |||||||||
| Failure to Sense | 1 | |||||||||
